Idera Pharmaceuticals, Inc. (IDRA) Misses Q2 EPS by 1c
Get Alerts IDRA Hot Sheet
Join SI Premium – FREE
Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) reported Q2 EPS of ($0.10), $0.01 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $38 thousand, versus $29 thousand reported last year.
For earnings history and earnings-related data on Idera Pharmaceuticals, Inc. (IDRA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: RH, Estee Lauder rise; Tesla falls
- Planet Labs (PL) Reports In-Line Q4 EPS, provides guidance
- CVD Equipment (CVV) Reports Q4 Loss of $0.33
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!